Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.

Singh, K; Crossan, C; Laba, TL; Roy, A; Hayes, A; Salam, A; Jan, S; Lord, J; Tandon, N; Rodgers, A; +3 more... Patel, A; Thom, S; Prabhakaran, D; (2018) Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial. International journal of cardiology. ISSN 0167-5273 DOI: https://doi.org/10.1016/j.ijcard.2018.03.082

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.ijcard.2018.03.082

Abstract

Share

Download

Filename: Cost-effectiveness of a fixed dose_GREEN AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar